立方体使用和管间炎的风险:使用FDA不良事件报告系统进行现实世界的信号检测分析
Ayesha Yasmeen1,2, Mamoon H Syed1,2, Amani Khardali1,2
1Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Frontiers in medicine
|November 27, 2025
概括
类药物可能与管间炎 (TIN) 相关,这是一种脏疾病,特别是在老年人中. 现实数据显示,他类药物相关的TIN的安全信号越来越大,需要进行临床考虑.
科学领域:
- 药监和药物安全 药监和药物安全
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
背景情况:
- 类药物通常用于预防心血管疾病.
- 对于他类药物的不良影响是令人担忧的,包括罕见的管介质炎 (TIN) 报告.
- 现实世界的数据对于评估药物安全信号至关重要.
研究的目的:
- 调查他类药物使用与管间炎 (TIN) 之间的潜在关联.
- 分析药监数据以检测与他类药物相关的TIN的安全信号.
- 评估随着时间的推移与他类药物相关的TIN报告的趋势.
主要方法:
- 对美国FDA不良事件报告系统 (FAERS) 2017-2024年数据的分析.
- 使用MedDRA首选术语识别TIN案件.
- 不成比例分析 (ROR,PRR,EBGM,IC) 以检测安全信号,分层分为COVID-19之前和之后的时期.
主要成果:
- 确定了120例与他类药物使用相关的TIN病例.
- 从2021年开始,与他类药物相关的TIN出现了显著的安全信号,在2024年达到顶峰.
- 大多数受影响的患者年龄≥60岁,超过65%需要住院治疗.
结论:
- 现实数据表明,他类药物使用与TIN之间存在统计学上显著的关联,特别是在老年人中.
- 临床医生应考虑在接受他类药物治疗的患者中使用TIN,患者有不明原因的功能障碍.
- 需要进一步的研究来证实这种关联,并确定风险因素.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
FDA Approved Drugs: Changes to Approved Drugs
231
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
231
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
